These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38754032)

  • 21. IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms.
    Tse BW; Russell PJ; Lochner M; Förster I; Power CA
    PLoS One; 2011; 6(9):e24241. PubMed ID: 21935389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay.
    Sedegah M
    Methods Mol Biol; 2015; 1325():197-205. PubMed ID: 26450390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.
    Kleinnijenhuis J; Quintin J; Preijers F; Benn CS; Joosten LA; Jacobs C; van Loenhout J; Xavier RJ; Aaby P; van der Meer JW; van Crevel R; Netea MG
    J Innate Immun; 2014; 6(2):152-8. PubMed ID: 24192057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice.
    Lee J; Brehm MA; Greiner D; Shultz LD; Kornfeld H
    BMC Immunol; 2013 Dec; 14():53. PubMed ID: 24313934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot.
    Barrios EL; Mazer MB; McGonagill PW; Bergmann CB; Goodman MD; Gould RW; Rao M; Polcz VE; Davis RJ; Del Toro DE; Dirain ML; Dram A; Hale LO; Heidarian M; Kim CY; Kucaba TA; Lanz JP; McCray AE; Meszaros S; Miles S; Nelson CR; Rocha IL; Silva EE; Ungaro RF; Walton AH; Xu J; Zeumer-Spataro L; Drewry AM; Liang M; Bible LE; Loftus TJ; Turnbull IR; Efron PA; Remy KE; Brakenridge SC; Badovinac VP; Griffith TS; Moldawer LL; Hotchkiss RS; Caldwell CC
    JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38100268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-12 elispot assays to detect and enumerate IL-12 secreting cells.
    Ozenci V; Kouwenhoven M; Press R; Link H; Huang YM
    Cytokine; 2000 Aug; 12(8):1218-24. PubMed ID: 10930299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 and CD8 T Cell Memory Interactions Alter Innate Immunity and Organ Injury in the CLP Sepsis Model.
    Taylor MD; Fernandes TD; Kelly AP; Abraham MN; Deutschman CS
    Front Immunol; 2020; 11():563402. PubMed ID: 33329524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELISpot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8, MIP-1beta and TNF-alpha.
    Smedman C; Gårdlund B; Nihlmark K; Gille-Johnson P; Andersson J; Paulie S
    J Immunol Methods; 2009 Jul; 346(1-2):1-8. PubMed ID: 19358850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.
    Edwards LA; Nistala K; Mills DC; Stephenson HN; Zilbauer M; Wren BW; Dorrell N; Lindley KJ; Wedderburn LR; Bajaj-Elliott M
    PLoS One; 2010 Nov; 5(11):e15398. PubMed ID: 21085698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium.
    Waerlop G; Leroux-Roels G; Lambe T; Bellamy D; Medaglini D; Pettini E; Cox RJ; Trieu MC; Davies R; Bredholt G; Montomoli E; Gianchecchi E; Clement F
    Front Immunol; 2022; 13():984642. PubMed ID: 36159843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
    Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
    J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury.
    Shelley O; Murphy T; Paterson H; Mannick JA; Lederer JA
    Shock; 2003 Aug; 20(2):123-9. PubMed ID: 12865655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis.
    Grailer JJ; Kalbitz M; Zetoune FS; Ward PA
    J Innate Immun; 2014; 6(5):695-705. PubMed ID: 24861731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical Model of Innate and Adaptive Immunity of Sepsis: A Modeling and Simulation Study of Infectious Disease.
    Shi Z; Wu CH; Ben-Arieh D; Simpson SQ
    Biomed Res Int; 2015; 2015():504259. PubMed ID: 26446682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septic mucosal intraepithelial lymphoid immune suppression: role for nitric oxide not interleukin-10 or transforming growth factor-beta.
    Chung CS; Song GY; Wang W; Chaudry IH; Ayala A
    J Trauma; 2000 May; 48(5):807-12; discussion 812-3. PubMed ID: 10823523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression in patients who die of sepsis and multiple organ failure.
    Boomer JS; To K; Chang KC; Takasu O; Osborne DF; Walton AH; Bricker TL; Jarman SD; Kreisel D; Krupnick AS; Srivastava A; Swanson PE; Green JM; Hotchkiss RS
    JAMA; 2011 Dec; 306(23):2594-605. PubMed ID: 22187279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nickel induces secretion of IFN-gamma by splenic natural killer cells.
    Kim JY; Huh K; Lee KY; Yang JM; Kim TJ
    Exp Mol Med; 2009 Apr; 41(4):288-95. PubMed ID: 19299918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELISpot for measuring human immune responses to vaccines.
    Slota M; Lim JB; Dang Y; Disis ML
    Expert Rev Vaccines; 2011 Mar; 10(3):299-306. PubMed ID: 21434798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune response in Th1- and Th2-dominant mouse strains.
    Watanabe H; Numata K; Ito T; Takagi K; Matsukawa A
    Shock; 2004 Nov; 22(5):460-6. PubMed ID: 15489639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.
    Cao Y; Feng Y; Zhang Y; Zhu X; Jin F
    BMC Cancer; 2016 Jun; 16():343. PubMed ID: 27246354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.